{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:14:30Z","timestamp":1792451670351,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/nrcardio.2010.123","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T03:53:12Z","timestamp":1281412392000},"page":"577-584","source":"Crossref","is-referenced-by-count":126,"title":["Salt, aldosterone, and insulin resistance: impact on the cardiovascular system"],"prefix":"10.1038","volume":"7","author":[{"given":"Guido","family":"Lastra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Dhuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"BFnrcardio2010123_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.ackd.2006.07.011","volume":"13","author":"G Lastra","year":"2006","unstructured":"Lastra, G., Manrique, C. M. & Sowers, J. R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv. Chronic Kidney Dis. 13, 365\u2013373 (2006).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrcardio2010123_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","volume":"71","author":"G Lastra-Lastra","year":"2009","unstructured":"Lastra-Lastra, G., Sowers, J. R., Restrepo-Erazo, K., Manrique-Acevedo, C. & Lastra-Gonz\u00e1lez, G. Role of aldosterone and angiotensin II in insulin resistance: an update. Clin. Endocrinol. (Oxf.) 71, 1\u20136 (2009).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrcardio2010123_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.HYP.0000066844.63035.3A","volume":"41","author":"P Strazzullo","year":"2003","unstructured":"Strazzullo, P., Galletti, F. & Barba, G. Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension 41, 1000\u20131005 (2003).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(82)92462-X","volume":"1","author":"HE De Wardener","year":"1982","unstructured":"De Wardener, H. E. & MacGregor, G. A. The natriuretic hormone and essential hypertension. Lancet 1, 1450\u20131454 (1982).","journal-title":"Lancet"},{"key":"BFnrcardio2010123_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archinte.1986.00360130217028","volume":"146","author":"MC Houston","year":"1986","unstructured":"Houston, M. C. Sodium and hypertension. A review. Arch. Intern. Med. 146, 179\u2013185 (1986).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio2010123_CR6","doi-asserted-by":"publisher","first-page":"H2039","DOI":"10.1152\/ajpheart.00325.2007","volume":"293","author":"SN Orlov","year":"2007","unstructured":"Orlov, S. N. & Mongin, A. A. Salt-sensing mechanisms in blood pressure regulation and hypertension. Am. J. Physiol. Heart Circ. Physiol. 293, H2039\u2013H2053 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2010123_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0021-9681(80)90032-6","volume":"33","author":"CE Grim","year":"1980","unstructured":"Grim, C. E.  et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J. Chron. Dis. 33, 155\u2013162 (1980).","journal-title":"J. Chron. Dis."},{"key":"BFnrcardio2010123_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/1047-2797(94)00055-X","volume":"5","author":"FM Sacks","year":"1995","unstructured":"Sacks, F. M.  et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH): A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann. Epidemiol. 5, 108\u2013118 (1995).","journal-title":"Ann. Epidemiol."},{"key":"BFnrcardio2010123_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks, F. M.  et al. for the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 344, 3\u201310 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR10","first-page":"127","volume":"8","author":"MH Weinberger","year":"1996","unstructured":"Weinberger, M. H., Miller, J. Z., Luft, F. C., Grim, C. E. & Fineberg, N. S. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8, 127\u2013134 (1996).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","volume":"27","author":"MH Weinberger","year":"1996","unstructured":"Weinberger, M. H. Salt sensitivity of blood pressure in humans. Hypertension 27, 481\u2013490 (1996).","journal-title":"Hypertension"},{"issue":"Suppl. 3","key":"BFnrcardio2010123_CR12","doi-asserted-by":"publisher","first-page":"247S","DOI":"10.1080\/07315724.2006.10719574","volume":"25","author":"V Franco","year":"2006","unstructured":"Franco, V. & Oparil, S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J. Am. Coll. Nutr. 25 (Suppl. 3), 247S\u2013255S (2006).","journal-title":"J. Am. Coll. Nutr."},{"issue":"Suppl. 1","key":"BFnrcardio2010123_CR13","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1097\/00005344-198400061-00034","volume":"6","author":"F Skrabal","year":"1984","unstructured":"Skrabal, F., Hamberger, L. & Ledochowski, M. Inherited salt sensitivity in normotensive humans as a cause of essential hypertension: a new concept. J. Cardiovasc. Pharmacol. 6 (Suppl. 1), S215\u2013S223 (1984).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnrcardio2010123_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.HYP.37.2.429","volume":"27","author":"MH Weinberger","year":"2001","unstructured":"Weinberger, M. H., Fineberg, N. S., Fineberg, E. & Weinberger, M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 27, 429\u2013432 (2001).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM198908313210905","volume":"321","author":"AP Rocchini","year":"1989","unstructured":"Rocchini, A. P.  et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N. Engl. J. Med. 321, 580\u2013585 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0895-7061(95)00152-F","volume":"8","author":"I Zavaroni","year":"1995","unstructured":"Zavaroni, I.  et al. Association between salt sensitivity and insulin concentrations in patients with hypertension. Am. J. Hypertens. 8, 855\u2013858 (1995).","journal-title":"Am. J. Hypertens."},{"key":"BFnrcardio2010123_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00004872-199104000-00004","volume":"9","author":"AM Sharma","year":"1991","unstructured":"Sharma, A. M., Ruland, K., Spies, K. P. & Distler, A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J. Hypertens. 9, 329\u2013335 (1991).","journal-title":"J. Hypertens."},{"key":"BFnrcardio2010123_CR18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/00004872-199715120-00017","volume":"15","author":"F Galletti","year":"1997","unstructured":"Galletti, F.  et al. NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J. Hypertens. 15, 1485\u20131491 (1997).","journal-title":"J. Hypertens."},{"key":"BFnrcardio2010123_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.HYP.35.3.827","volume":"35","author":"O Melander","year":"2000","unstructured":"Melander, O., Groop, L. & Hulth\u00e9n, U. L. Effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity. Hypertension 35, 827\u2013831 (2000).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1159\/000126593","volume":"5","author":"MK Agarwal","year":"1993","unstructured":"Agarwal, M. K., Mirshahi, F., Mirshahi, M. & Rostene, W. Immunochemical detection of the mineralocorticoid receptor in rat brain. Neuroendocrinology 5, 575\u2013580 (1993).","journal-title":"Neuroendocrinology"},{"key":"BFnrcardio2010123_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cne.20808","volume":"494","author":"JC Geerling","year":"2006","unstructured":"Geerling, J. C., Kawata, M. & Loewy, A. D. Aldosterone-sensitive neurons in the rat central nervous system. J. Comp. Neurol. 494, 515\u2013527 (2006).","journal-title":"J. Comp. Neurol."},{"key":"BFnrcardio2010123_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.1.06017","volume":"186","author":"JM Connell","year":"2005","unstructured":"Connell, J. M. & Davies, E. The new biology of aldosterone. J. Endocrinol. 186, 1\u201320 (2005).","journal-title":"J. Endocrinol."},{"key":"BFnrcardio2010123_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/endo-118-2-819","volume":"118","author":"EP Gomez-Sanchez","year":"1986","unstructured":"Gomez-Sanchez, E. P. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118, 819\u2013823 (1986).","journal-title":"Endocrinology"},{"key":"BFnrcardio2010123_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.HYP.0000033468.84826.A7","volume":"40","author":"GF DiBona","year":"2002","unstructured":"DiBona, G. F. & Sawin, L. L. Effect of arterial baroreceptor denervation on sodium balance. Hypertension 40, 547\u2013551 (2002).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1046\/j.1523-1755.2000.00972.x","volume":"57","author":"RR Sakai","year":"2000","unstructured":"Sakai, R. R., McEwen, B. S., Fluharty, S. J. & Ma, L. Y. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake. Kidney Int. 57, 1337\u20131345 (2000).","journal-title":"Kidney Int."},{"key":"BFnrcardio2010123_CR26","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00126.2004","volume":"287","author":"BS Huang","year":"2004","unstructured":"Huang, B. S., Van Vliet, B. N. & Leenen, F. H. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am. J. Physiol. Heart Circ. Physiol. 287, H1160\u2013H2116 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2010123_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.hco.0000231398.64362.94","volume":"21","author":"BS Huang","year":"2006","unstructured":"Huang, B. S., Amin, M. S. & Leenen, F. H. The central role of the brain in salt-sensitive hypertension. Curr. Opin. Cardiol. 21, 295\u2013304 (2006).","journal-title":"Curr. Opin. Cardiol."},{"key":"BFnrcardio2010123_CR28","doi-asserted-by":"publisher","first-page":"H1109","DOI":"10.1152\/ajpheart.00024.2006","volume":"291","author":"BS Huang","year":"2006","unstructured":"Huang, B. S.  et al. Activation of brain renin\u2013angiotensin\u2013aldosterone system by central sodium in Wistar rats. Am. J. Physiol. Heart Circ. Physiol. 291, H1109\u2013H1117 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2010123_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/01.HYP.0000238140.06251.7a","volume":"48","author":"TL O'Donaughy","year":"2006","unstructured":"O'Donaughy, T. L., Qi, Y. & Brooks, V. L. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats. Hypertension 48, 658\u2013663 (2006).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR30","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1161\/HYPERTENSIONAHA.108.111948","volume":"52","author":"BS Huang","year":"2008","unstructured":"Huang, B. S., Zheng, H., Patel, K. P. & Leenen, F. H. Central infusion of aldosterone decreases nNOS and increases AT1R and components of NADPH oxidase within the PVN [abstract P015]. Hypertension 52, e59 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR31","doi-asserted-by":"publisher","first-page":"H1067","DOI":"10.1152\/ajpheart.01131.2007","volume":"294","author":"ZH Zhang","year":"2008","unstructured":"Zhang, Z. H., Yu, Y., Kang, Y. M., Wei, S. G. & Felder, R. B. Aldosterone acts centrally to increase brain renin\u2013angiotensin system activity and oxidative stress in normal rats. Am. J. Physiol. Heart Circ. Physiol. 294, H1067\u2013H1074 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2010123_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/HYPERTENSIONAHA.107.099796","volume":"51","author":"Y Yu","year":"2008","unstructured":"Yu, Y.  et al. Does aldosterone upregulate the brain renin\u2013angiotensin system in rats with heart failure? Hypertension 51, 727\u2013733 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1139\/Y09-067","volume":"87","author":"KV Wescott","year":"2009","unstructured":"Wescott, K. V., Huang, B. S. & Leenen, F. H. Brain renin\u2013angiotensin\u2013aldosterone system and ventricular remodeling after myocardial infarct: a review. Can. J. Physiol. Pharmacol. 87, 979\u2013988 (2009).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BFnrcardio2010123_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1113\/expphysiol.2008.045948","volume":"95","author":"RB Felder","year":"2010","unstructured":"Felder, R. B. Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp. Physiol. 95, 19\u201325 (2010).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio2010123_CR35","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1111\/j.1440-1681.2009.05234.x","volume":"37","author":"P Shi","year":"2010","unstructured":"Shi, P., Raizada, M. K. & Sumners, C. Brain cytokines as neuromodulators in cardiovascular control. Clin. Exp. Pharmacol. Physiol. 37, e52\u2013e57 (2010).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFnrcardio2010123_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1749-6632.2000.tb05426.x","volume":"917","author":"AJ Dunn","year":"2000","unstructured":"Dunn, A. J. Cytokine activation of the HPA axis. Ann. NY Acad. Sci. 917, 608\u2013617 (2000).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrcardio2010123_CR37","doi-asserted-by":"publisher","first-page":"R328","DOI":"10.1152\/ajpregu.00376.2002","volume":"284","author":"J Francis","year":"2003","unstructured":"Francis, J., Weiss, R. M., Johnson, A. K. & Felder, R. B. Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R328\u2013R335 (2003).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrcardio2010123_CR38","doi-asserted-by":"publisher","first-page":"R1402","DOI":"10.1152\/ajpregu.00027.2003","volume":"285","author":"J Francis","year":"2003","unstructured":"Francis, J., Beltz, T., Johnson, A. K. & Felder, R. B. Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R1402\u2013R1409 (2003).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrcardio2010123_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11892-006-0036-5","volume":"6","author":"G Lastra","year":"2006","unstructured":"Lastra, G., Manrique, C., McFarlane, S. I. & Sowers, J. R. Cardiometabolic syndrome and chronic kidney disease. Curr. Diab. Rep. 6, 207\u2013212 (2006).","journal-title":"Curr. Diab. Rep."},{"key":"BFnrcardio2010123_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1172\/JCI111776","volume":"75","author":"M Modan","year":"1985","unstructured":"Modan, M.  et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J. Clin. Invest. 75, 809\u2013817 (1985).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2010123_CR41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/NEJM199604113341504","volume":"334","author":"JP Despr\u00e9s","year":"1996","unstructured":"Despr\u00e9s, J. P.  et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334, 952\u2013958 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","volume":"84","author":"A Sp\u00e4t","year":"2004","unstructured":"Sp\u00e4t, A. & Hunyady, L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol. Rev. 84, 489\u2013539 (2004).","journal-title":"Physiol. Rev."},{"key":"BFnrcardio2010123_CR43","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla, C. G. & Weber, K. T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 120, 893\u2013901 (1992).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrcardio2010123_CR44","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1210\/en.2006-1691","volume":"148","author":"S Stas","year":"2007","unstructured":"Stas, S.  et al. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin\u2013angiotensin\u2013aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Endocrinology 148, 3773\u20133780 (2007).","journal-title":"Endocrinology"},{"key":"BFnrcardio2010123_CR45","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","volume":"295","author":"G Lastra","year":"2008","unstructured":"Lastra, G.  et al. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am. J. Physiol. Endocrinol. Metab. 295, E110\u2013E116 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrcardio2010123_CR46","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","volume":"43","author":"DH Endemann","year":"2004","unstructured":"Endemann, D. H., Touyz, R. M., Iglarz, M., Savoia, C. & Schiffrin, E. L. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 43, 1252\u20131257 (2004).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","volume":"48","author":"M Bochud","year":"2006","unstructured":"Bochud, M.  et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 48, 239\u2013245 (2006).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-2796.2004.01390.x","volume":"256","author":"JC Verhave","year":"2004","unstructured":"Verhave, J. C.  et al. for the PREVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects. J. Intern. Med. 256, 324\u2013330 (2004).","journal-title":"J. Intern. Med."},{"key":"BFnrcardio2010123_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/HYPERTENSIONAHA.109.149062","volume":"55","author":"T Fujita","year":"2010","unstructured":"Fujita, T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 55, 813\u2013818 (2010).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR50","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/HYPERTENSIONAHA.108.121269","volume":"52","author":"AC Montezano","year":"2008","unstructured":"Montezano, A. C. & Touyz, R. M. Networking between systemic angiotensin II and cardiac mineralocorticoid receptors. Hypertension 52, 1016\u20131018 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1253\/circj.72.1346","volume":"72","author":"M Yamamuro","year":"2008","unstructured":"Yamamuro, M.  et al. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes. Circ. J. 72, 1346\u20131350 (2008).","journal-title":"Circ. J."},{"key":"BFnrcardio2010123_CR52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","volume":"52","author":"AD Zhang","year":"2008","unstructured":"Zhang, A. D.  et al. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension 52, 1060\u20131067 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.ackd.2006.07.011","volume":"13","author":"G Lastra","year":"2006","unstructured":"Lastra, G., Manrique, C. M. & Sowers, J. R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv. Chronic Kidney Dis. 13, 365\u2013373 (2006).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrcardio2010123_CR54","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1210\/jc.2008-0251","volume":"93","author":"GP Rossi","year":"2008","unstructured":"Rossi, G. P.  et al. for the Primary Aldosteronism Prevalence in hypertension Study Investigators. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J. Clin. Endocrinol. Metab. 93, 2566\u20132571 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrcardio2010123_CR55","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1096\/fj.07-9412com","volume":"22","author":"JH Jeon","year":"2008","unstructured":"Jeon, J. H.  et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 22, 1502\u20131511 (2008).","journal-title":"FASEB J."},{"key":"BFnrcardio2010123_CR56","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1096\/fj.06-7970com","volume":"21","author":"M Caprio","year":"2007","unstructured":"Caprio, M.  et al. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 21, 2185\u20132194 (2007).","journal-title":"FASEB J."},{"key":"BFnrcardio2010123_CR57","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/HJH.0b013e328300a232","volume":"26","author":"H Wang","year":"2008","unstructured":"Wang, H.  et al. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J. Hypertension 26, 1453\u20131462 (2008).","journal-title":"J. Hypertension"},{"issue":"9","key":"BFnrcardio2010123_CR58","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/ndt\/gfq197","volume":"25","author":"H. Kawarazaki","year":"2010","unstructured":"Kawarazaki, H.  et al. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats. Nephrol. Dial. Transplant. doi: 10.1093\/ndt\/gfq197.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"BFnrcardio2010123_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","volume":"50","author":"M Nagase","year":"2007","unstructured":"Nagase, M., Matsui, H., Shibata, S., Gotoda, T. & Fujita, T. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 50, 877\u2013883 (2007).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR60","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. & Alexander, R. W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141\u20131148 (1994).","journal-title":"Circ. Res."},{"key":"BFnrcardio2010123_CR61","doi-asserted-by":"publisher","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","volume":"293","author":"SA Copper","year":"2007","unstructured":"Copper, S. A.  et al. Renin\u2013angiotensin\u2013aldosterone system and oxidative stress in cardiovascular insulin resistance. Am. J. Physiol. Heart Circ. Physiol. 293, H2009\u2013H2023 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2010123_CR62","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","volume":"49","author":"JC Henquin","year":"2000","unstructured":"Henquin, J. C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49, 1751\u20131760 (2000).","journal-title":"Diabetes"},{"key":"BFnrcardio2010123_CR63","first-page":"755","volume":"8","author":"K Shimamoto","year":"1994","unstructured":"Shimamoto, K.  et al. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J. Hum. Hypertens. 8, 755\u2013759 (1994).","journal-title":"J. Hum. Hypertens."},{"key":"BFnrcardio2010123_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","volume":"51","author":"NJ Brown","year":"2008","unstructured":"Brown, N. J. Aldosterone and vascular inflammation. Hypertension 51, 161\u2013167 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio2010123_CR65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1524-6175.2005.04617.x","volume":"7","author":"C Manrique","year":"2005","unstructured":"Manrique, C., Lastra, G., Whaley-Connel, A. & Sowers, J. R. Hypertension and the cardiometabolic syndrome. J. Clin. Hypertens. (Greenwich) 7, 471\u2013476 (2005).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"BFnrcardio2010123_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf, S.  et al. for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 145\u2013153 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","volume":"353","author":"L Hansson","year":"1999","unstructured":"Hansson, L.  et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611\u2013616 (1999).","journal-title":"Lancet"},{"key":"BFnrcardio2010123_CR68","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer, M. A.  et al. for the CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362, 759\u2013766 (2003).","journal-title":"Lancet"},{"key":"BFnrcardio2010123_CR69","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/archinte.166.20.2191","volume":"166","author":"JI Barzilay","year":"2006","unstructured":"Barzilay, J. I.  et al. for the ALLHAT Collaborative Research Group. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of hypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med. 166, 2191\u20132201 (2006).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio2010123_CR70","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0002-9149(97)89163-1","volume":"77","author":"DM Shindler","year":"1996","unstructured":"Shindler, D. M.  et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am. J. Cardiol. 77, 1017\u20131020 (1996).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010123_CR71","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"RB Devereux","year":"2004","unstructured":"Devereux, R. B.  et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110, 1456\u20131462 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2010123_CR72","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt, B.  et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709\u2013717 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR73","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt, B.  et al. for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309\u20131321 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR74","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa065061","volume":"355","author":"J Bosch","year":"2006","unstructured":"Bosch, J.  et al. for the DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N. Engl. J. Med. 355, 1551\u20131562 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010123_CR75","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","volume":"150","author":"JR Sowers","year":"2009","unstructured":"Sowers, J. R., Whaley-Connell, A. & Epstein, M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann. Intern. Med. 150, 776\u2013783 (2009).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio2010123_CR76","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0909392","volume":"362","author":"JJ McMurray","year":"2010","unstructured":"McMurray, J. J.  et al. for the NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N. Engl. J. Med. 362, 1477\u20131490 (2010).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.123","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:45:21Z","timestamp":1684453521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2010.123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFnrcardio2010123"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2010.123","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}